Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Telmisartan on Red Blood Cell Function and Microcirculatory Perfusion (ITEM)
2007-002765-12Phase 4Completed
- Sponsor
- RWTH Aachen University
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of telmisartan in hypertension (HTN) and type 2 diabetes mellitus (T2DM), sponsored by RWTH Aachen University. Primary endpoint: Increase in red blood cell deformability. Started Jul 2007; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-002765-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002765-12.